RecruitingNot ApplicableNCT04794075

Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer

Programme d'Éducation Thérapeutique et d'Accompagnement Infirmier Vers Les Soins de Support, Chez Les Patientes Sous Hormonothérapie Pour un Cancer du Sein Non métastatique


Sponsor

Centre Hospitalier Emile Roux

Enrollment

300 participants

Start Date

Aug 9, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

To compare the efficacy of the addition of a therapeutic education program combined with nursing phone follow-up, compared to conventional management alone, on the management of adverse events (AEs) related to adjuvant hormone therapy during the first year of treatment in patients with non-metastatic breast cancer.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This French study is testing whether a structured nursing education and support program can help women with non-metastatic breast cancer better manage the side effects of hormone therapy (such as anti-estrogens or aromatase inhibitors). These medications are effective but often cause side effects that lead women to stop taking them. Better support may improve adherence and quality of life. **You may be eligible if...** - You are a woman between 18 and 75 years old - You have non-metastatic breast cancer and your treatment team has recommended adjuvant hormone therapy - Your overall health is reasonably good (ECOG ≤2) - You can read and understand French - You have internet access for online questionnaires **You may NOT be eligible if...** - You have metastatic (stage IV) breast cancer - You do not understand French - You do not have internet access - You are under 18 or over 75 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTherapeutic Education and Nursing Support Program for Supportive Care

In addition to the conventional oncology follow-up, patients will participate in an initial educational assessment day within 15 days before or after their first dose of hormone therapy. A discussion between the patient and the pivot nurse will then make it possible to define personalized objectives, thus guiding the choice of workshops in the outpatient educational program.


Locations(9)

Centre Hospitalier de Bourg-en-Bresse / Fleyriat

Bourg-en-Bresse, France

Clinique De L'infirmerie Protestante De Lyon

Caluire-et-Cuire, France

CH de Carcassonne

Carcassonne, France

CHAL - Centre Hospitalier Alpes Léman

Contamine-sur-Arve, France

Centre Hospitalier Emile Roux

Le Puy-en-Velay, France

Centre Hospitalier François Quesnay

Mantes-la-Jolie, France

Groupement Hospitalier Portes de Provence

Montélimar, France

Centre Hospitalier Universitaire de Saint-Étienne - Hôpital Nord

Saint-Priest-en-Jarez, France

Médipôle Lyon-Villeurbanne

Villeurbanne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04794075